Related Experiment Video
Updated: Sep 12, 2026

Enrichment of NK Cells from Human Blood with the RosetteSep Kit from StemCell Technologies
Published on: October 1, 2007
Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation
J R Pawloski1, R V Swaminathan, J S Stamler
1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Background:
Nitric oxide (NO) and related molecules are thought to inhibit human platelet aggregation by raising levels of cGMP.
Methods And Results:
Both oxidative stress (reactive oxygen species) and hemoglobin (Hb) seem to oppose NO effects. A major fraction of NO in the blood is bound to thiols of Hb, forming S-nitrosohemoglobin (SNO-Hb), which releases the NO group on deoxygenation in the microcirculation. Here we show that (1) both cell-free and intraerythrocytic SNO-Hb (SNO-RBC) inhibit platelet aggregation, (2) the oxidation state of the hemes in Hb influences the response--SNO-metHb (which is functionally similar to SNO-deoxyHb) has greater platelet inhibitory effects than SNO-oxyHb, and (3) the mechanism of platelet inhibition by SNO-Hb is cGMP independent.
Conclusions:
We suggest that the RBC has evolved a means to counteract platelet activation in small vessels and the proaggregatory effects of oxidative stress by forming SNO-Hb.
Related Concept Videos
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Selectins
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...

